January 31, 2024 US FDA warns consumers over copycats of Bausch + Lomb eye drops The U.S. Food and Drug Administration (FDA) on Wednesday warned consumers not to use unapproved eye drops that ...

Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% of ... intraocular lenses, and eye surgery products, and made revenues of $4.15 billion last year.

Bausch + Lomb Corporation (NYSE:BLCO; TSX:BLCO), a prominent player in the global eye health market with a market capitalization of $5.78 billion, has been navigating a complex landscape of ...

Simons, Robert L., Alex C. Sapir '97, and Indra Reinbergs. "Bausch & Lomb, Inc.: Pressure to Perform." Harvard Business School Case 198-009, April 1998. (Revised June ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced an ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, issued the following update on a potential sale, which was ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the commercial launch of the enVista Aspire ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its fourth-quarter and full-year 2024 financial ...

VAUGHAN, Ontario (AP) — VAUGHAN, Ontario (AP) — Bausch + Lomb Corporation (BLCO) on Wednesday reported a loss of $3 million in its fourth quarter. On a per-share basis, the Vaughan ...

(RTTNews) - Bausch + Lomb Corp. (BLCO), Wednesday announced the financial outlook, expecting revenue of $4.950 billion to $5.050 billion for the fiscal year 2025. Analysts, on average, estimates ...